372 related articles for article (PubMed ID: 10634643)
1. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
2. High expression of endogenous bcl-2 and bcl-xL in thymic lymphomas do not diminish their sensitivity to etoposide-induced apoptosis.
Matuszyk J; Kalas W; Cebrat M; Strzadala L
Anticancer Res; 2001; 21(4A):2677-80. PubMed ID: 11724338
[TBL] [Abstract][Full Text] [Related]
3. Changes in glucocorticoid-induced apoptosis and in expression of Bcl-2 protein during long-term culture of thymic lymphoma.
Kobzdej M; Matuszyk J; Zioło E; Strzadała L
Arch Immunol Ther Exp (Warsz); 2000; 48(1):43-6. PubMed ID: 10722231
[TBL] [Abstract][Full Text] [Related]
4. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway.
Lin K; Abraham KM
Int Immunol; 1997 Feb; 9(2):291-306. PubMed ID: 9040011
[TBL] [Abstract][Full Text] [Related]
5. Thymic lymphomas are resistant to Nur77-mediated apoptosis.
Matuszyk J; Kobzdej M; Ziolo E; Kalas W; Kisielow P; Strzadala L
Biochem Biophys Res Commun; 1998 Aug; 249(1):279-82. PubMed ID: 9705872
[TBL] [Abstract][Full Text] [Related]
6. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
Hueber AO; Bösser S; Zörnig M
Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
[TBL] [Abstract][Full Text] [Related]
7. [Disturbance of signalling pathways for apoptosis in thymic lymphomas from TCR transgenic mice].
Strzadała L
Postepy Hig Med Dosw; 1999; 53(2):345-50. PubMed ID: 10355299
[TBL] [Abstract][Full Text] [Related]
8. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
9. Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells.
McGlynn AP; Padua RA; Burnett AK; Darley RL
Leuk Res; 2000 Jan; 24(1):47-54. PubMed ID: 10634645
[TBL] [Abstract][Full Text] [Related]
10. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice.
Blyth K; Stewart M; Bell M; James C; Evan G; Neil JC; Cameron ER
Oncogene; 2000 Feb; 19(6):773-82. PubMed ID: 10698495
[TBL] [Abstract][Full Text] [Related]
12. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
14. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
15. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.
Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW
Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984
[TBL] [Abstract][Full Text] [Related]
16. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.
Strzadala L; Miazek A; Matuszyk J; Kisielow P
Int Immunol; 1997 Jan; 9(1):127-38. PubMed ID: 9043954
[TBL] [Abstract][Full Text] [Related]
17. The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus.
Tao W; Teh SJ; Melhado I; Jirik F; Korsmeyer SJ; Teh HS
J Exp Med; 1994 Jan; 179(1):145-53. PubMed ID: 8270861
[TBL] [Abstract][Full Text] [Related]
18. TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas.
Gomez G; Clarkin KZ; Kraig E; Infante AJ; Richie ER
Int Immunol; 2000 Mar; 12(3):263-70. PubMed ID: 10700461
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
Klinger MB; Guilbault B; Goulding RE; Kay RJ
Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]